Abstract
Tyrosinase (EC 1.14.18.1) is known to be the rate-limiting enzyme responsible for catalyzing the first two steps in the synthesis of melanin pigments that determine the coloring of hair, skin and eyes. Tyrosinase catalyzes two- sequence distinct bio-reactions in pigment productions: L-tyrosine to L-dopa (hydroxylation); and L-dopa to dopaquinone (oxidation). The inhibition of tyrosinase has been established as one of the major strategies to regulate the production of melanin and the inhibitors are used to treat hyper-pigmentation and other unwanted effects from melanogenesis. There are now a variety of medicaments inhibiting melanin synthesis to treat excess melanin production or hyper-pigmentation of human skin, including the usage of natural plant extracts or chemically synthesized compounds. Recently, due to an increasing emphasis on healthy concepts, attention has been drawn to the usage of naturally produced crude materials and drugs in cosmetics and pharmaceutical applications. In this review, we demonstrate melanogenic inhibitory factors such as flavonoids, stilbenes, simple phenolics, furans, triterpenes, alkaloids, and other synthetic compounds. The structure-activity relationships are classified in terms of their inhibition of tyrosinase functions and copper chelating activity.
Keywords: Alkaloids, flavonoids, furans, melanin, tyrosinase inhibitor, stilbenes, simple phenolics, triterpenes.
Current Organic Chemistry
Title:An Updated Organic Classification of Tyrosinase Inhibitors on Melanin Biosynthesis
Volume: 19 Issue: 1
Author(s): Chung-Yi Chen, Li-Ching Lin, Wen-Feng Yang, Jennifer Bordon and Hui-Min D. Wang
Affiliation:
Keywords: Alkaloids, flavonoids, furans, melanin, tyrosinase inhibitor, stilbenes, simple phenolics, triterpenes.
Abstract: Tyrosinase (EC 1.14.18.1) is known to be the rate-limiting enzyme responsible for catalyzing the first two steps in the synthesis of melanin pigments that determine the coloring of hair, skin and eyes. Tyrosinase catalyzes two- sequence distinct bio-reactions in pigment productions: L-tyrosine to L-dopa (hydroxylation); and L-dopa to dopaquinone (oxidation). The inhibition of tyrosinase has been established as one of the major strategies to regulate the production of melanin and the inhibitors are used to treat hyper-pigmentation and other unwanted effects from melanogenesis. There are now a variety of medicaments inhibiting melanin synthesis to treat excess melanin production or hyper-pigmentation of human skin, including the usage of natural plant extracts or chemically synthesized compounds. Recently, due to an increasing emphasis on healthy concepts, attention has been drawn to the usage of naturally produced crude materials and drugs in cosmetics and pharmaceutical applications. In this review, we demonstrate melanogenic inhibitory factors such as flavonoids, stilbenes, simple phenolics, furans, triterpenes, alkaloids, and other synthetic compounds. The structure-activity relationships are classified in terms of their inhibition of tyrosinase functions and copper chelating activity.
Export Options
About this article
Cite this article as:
Chen Chung-Yi, Lin Li-Ching, Yang Wen-Feng, Bordon Jennifer and D. Wang Hui-Min, An Updated Organic Classification of Tyrosinase Inhibitors on Melanin Biosynthesis, Current Organic Chemistry 2015; 19 (1) . https://dx.doi.org/10.2174/1385272819666141107224806
DOI https://dx.doi.org/10.2174/1385272819666141107224806 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
Call for Papers in Thematic Issues
Advances of Heterocyclic Chemistry with Pesticide Activity
Global food safety and security will continue to be a global concern for the next 50 years and beyond. Plant diseases have had a significant impact on food safety and security throughout the entire food chain, from primary production to consumption. While conventional chemical pesticides have been traditionally used for ...read more
Calculation design of covalent/metal organic framework based catalysts
This research area combines theoretical computation and screening with machine learning for the design of covalent/metal organic framework-based catalysts, bridging the disciplines of organic chemistry, physical chemistry, computational chemistry, materials science, and machine learning. It covers several critical aspects: designing and synthesizing organic catalysts for improved performance, applying computational methods ...read more
Carbohydrates conversion in biofuels and bioproducts
Biomass pretreatment, hydrolysis, and saccharification of carbohydrates, and sugars bioconversion in biofuels and bioproducts within a biorefinery framework. Carbohydrates derived from woody biomass, agricultural wastes, algae, sewage sludge, or any other lignocellulosic feedstock are included in this issue. Simulation, techno-economic analysis, and life cycle analysis of a biorefinery process are ...read more
Catalytic C-H bond activation as a tool for functionalization of heterocycles
The major topic is the functionalization of heterocycles through catalyzed C-H bond activation. The strategies based on C-H activation not only provide straightforward formation of C-C or C-X bonds but, more importantly, allow for the avoidance of pre-functionalization of one or two of the cross-coupling partners. The beneficial impact of ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
MDM2-p53 Interaction in Paediatric Solid Tumours: Preclinical Rationale, Biomarkers and Resistance
Current Drug Targets Learning from Nature: Bioinspired Strategies Towards Antimicrobial Nanostructured Systems
Current Topics in Medicinal Chemistry Genetic and Pharmacogenetic Aspects of Alcohol-Dependence
Current Pharmacogenomics Blood-Brain Barrier P-Glycoprotein Function in Neurodegenerative Disease
Current Pharmaceutical Design The Quest for Novel Biomarkers in Early Diagnosis of Diabetic Neuropathy
Current Proteomics Current Drug Therapy for Prostate Cancer: An Overview
Current Medicinal Chemistry - Anti-Cancer Agents Exploiting EPR in Polymer Drug Conjugate Delivery for Tumor Targeting
Current Pharmaceutical Design NK Cell Receptor and MHC Gene Polymorphisms, Potential Relevance in Malignancies
Current Cancer Therapy Reviews Neuroprotective Role of Hypothermia in Hypoxic-ischemic Brain Injury: Combined Therapies using Estrogen
Current Neuropharmacology Modulation of Sensitivity to Antitumor Agents by Targeting the MAPK Survival Pathway
Current Pharmaceutical Design Nanoparticle Systems Modulating Myeloid-Derived Suppressor Cells for Cancer Immunotherapy
Current Topics in Medicinal Chemistry Retrospective Observational Study to Evaluate Causality, Preventability and Severity of Adverse Drug Reaction Associated with Anticancer Drugs in a Tertiary Care Hospital in Northern India
Current Drug Safety Melatonin: Pharmacology, Functions and Therapeutic Benefits
Current Neuropharmacology Aflibercept (VEGF-TRAP): The Next Anti-VEGF Drug
Inflammation & Allergy - Drug Targets (Discontinued) Targeting Proliferating Cell Nuclear Antigen (PCNA) as an Effective Strategy to Inhibit Tumor Cell Proliferation
Current Cancer Drug Targets The Emerging Role of Poly(ADP-Ribose) Polymerase Inhibitors in Cancer Treatment
Current Drug Targets Cellular Senescence-Inducing Small Molecules for Cancer Treatment
Current Cancer Drug Targets Anti-Inflammatory Approaches that Target the Chemokine Network
Recent Patents on Inflammation & Allergy Drug Discovery Advances in Synergistic Combinations of Chinese Herbal Medicine for the Treatment of Cancer
Current Cancer Drug Targets Microsphere Based Improved Sunscreen Formulation of Ethylhexyl Methoxycinnamate
Current Drug Delivery